指南与共识血脂与心血管预防

家庭心脏康复:AACVPR、AHA与ACC科学声明

Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.
指南 / 共识 · J Am Coll Cardiol · 2019-05-13

该科学声明由美国心血管与肺康复协会、美国心脏协会和美国心脏病学会联合制定,旨在明确家庭心脏康复(HBCR)的核心要素、疗效、优势、局限与证据缺口。既往随机试验显示低至中等强度证据表明HBCR与中心型心脏康复在3至12个月临床结局改善上相似。声明认为HBCR可能适用于无法参加传统中心康复的临床稳定低至中危合格患者。

要点

  • HBCR通过远程指导与间接运动监督提供,主要在传统中心外进行。
  • 低至中等强度证据显示HBCR与中心康复在3至12个月结局改善相似。
  • HBCR可能适用于无法参加中心康复的稳定低至中危合格患者。

核心结论

  • HBCR可能适用于无法参加传统中心康复的临床稳定低至中危合格患者。

研究设计与样本

  • 科学声明由美国心血管与肺康复协会、美国心脏协会和美国心脏病学会联合制定。
  • 基于既往随机试验等证据总结HBCR的核心要素、疗效、优势、局限与证据缺口。

主要发现

  • 既往随机试验产生低至中等强度证据,表明HBCR与中心康复在3至12个月临床结局改善上相似。
  • HBCR已在英国、加拿大等国家成功部署,但多数美国医疗机构对该类项目缺乏经验。

关键数值与推荐

  • 低至中等强度证据支持HBCR与中心康复在3至12个月临床结局改善上相似。

临床怎么用

  • 对无法参加传统中心康复的临床稳定低至中危合格患者,可考虑HBCR作为合理选择。

局限性

  • 需额外研究与示范项目明确和扩展HBCR在老年人、女性、少数族裔及其他高危研究不足群体中的证据基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiac rehabilitation (CR) is an evidence-based intervention that uses patient education, health behavior modification, and exercise training to improve secondary prevention outcomes in patients with cardiovascular disease. CR programs reduce morbidity and mortality rates in adults with ischemic heart disease, heart failure, or cardiac surgery but are significantly underused, with only a minority of eligible patients participating in CR in the United States. New delivery strategies are urgently needed to improve participation. One potential strategy is home-based CR (HBCR). In contrast to center-based CR services, which are provided in a medically supervised facility, HBCR relies on remote coaching with indirect exercise supervision and is provided mostly or entirely outside of the traditional center-based setting. Although HBCR has been successfully deployed in the United Kingdom, Canada, and other countries, most US healthcare organizations have little to no experience with such programs. The purpose of this scientific statement is to identify the core components, efficacy, strengths, limitations, evidence gaps, and research necessary to guide the future delivery of HBCR in the United States. Previous randomized trials have generated low- to moderate-strength evidence that HBCR and center-based CR can achieve similar improvements in 3- to 12-month clinical outcomes. Although HBCR appears to hold promise in expanding the use of CR to eligible patients, additional research and demonstration projects are needed to clarify, strengthen, and extend the HBCR evidence base for key subgroups, including older adults, women, underrepresented minority groups, and other higher-risk and understudied groups. In the interim, we conclude that HBCR may be a reasonable option for selected clinically stable low- to moderate-risk patients who are eligible for CR but cannot attend a traditional center-based CR program.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Thomas RJ, Beatty AL, Beckie TM, et al. Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol. 2019. PMID: 31097258. doi:10.1016/j.jacc.2019.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。